Research graph
References from N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria. Local targets link to admitted publications; unresolved targets remain external evidence.
Progress in protein crystallography
10.2174/0929866523666160106153524 · 2016 · External reference
Computational methods in drug discovery
10.1124/pr.112.007336 · 2014 · External reference
On-the-Fly QM/MM Docking with Attracting Cavities
10.1021/acs.jcim.6b00406 · 2017 · External reference
10.1007/978-3-0348-8103-6
10.1007/978-3-0348-8103-6 · 2003 · External reference
Unresolved reference
External reference
1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents
10.1021/jm01240a021 · 1962 · External reference
Development of the quinolones
10.1093/jac/dkg212 · 2003 · External reference
Unresolved reference
2015 · External reference
FDA adds “black box” warning label to fluoroquinolone antibiotics
10.1136/bmj.a816 · 2008 · External reference
Safety of fluoroquinolones: An update
10.1155/2002/864789 · 2002 · External reference
Fluoroquinolone antimicrobial drugs
10.1503/cmaj.160938 · 2017 · External reference
Delafloxacin: an improved fluoroquinolone developed through advanced molecular engineering
10.2217/fmb-2018-0067 · 2018 · External reference
Antibiotics Currently in Global Clinical Development
External reference
Quinolones: action and resistance updated
10.2174/156802609789630947 · 2009 · External reference
Quinolone-mediated bacterial death
10.1128/aac.01617-06 · 2008 · External reference
Mode of action of fluoroquinolones
10.2165/00003495-199958002-00002 · 1999 · External reference
Mechanisms of action of antimicrobials: focus on fluoroquinolones
10.1086/319370 · 2001 · External reference
Type II Topoisomerases as Targets for Quinolone Antibacterials Turning Dr. Jekyll into Mr. Hyde
10.2174/1381612013398013 · 2001 · External reference
Using SAR and QSAR analysis to model the activity and structure of the quinolone-DNA complex
10.1016/0968-0896(96)83749-7 · 1996 · External reference
Structure-activity and structure-side-effect relationships for the quinolone antibacterials
10.1093/jac/33.4.685 · 1994 · External reference
Virtual Computational Chemistry Laboratory - Design and Description
10.1007/s10822-005-8694-y · 2005 · External reference
High-throughput assays for DNA gyrase and other topoisomerases
10.1093/nar/gkl504 · 2006 · External reference
Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: Structure-activity relationships and mode of action studies
10.1016/j.ejmech.2019.05.087 · 2019 · External reference
